SCIENTIFIC EVIDENCE

Bronchial epithelial transcriptomics and experimental validation reveal asthma severity-related neutrophilc signatures and potential treatments.

Communications biology
Yan Q, Zhang X, Xie Y, Yang J, Liu C, Zhang M, Zheng W, Lin X, Huang HT, Liu X, Jiang Y, Zhan SF, Huang X.

Publication Overview

Key findings, Countstar context, and access to the original paper.
2024
Immunology
Single-Cell Analysis
No items found.
Key Finding
The study's is to investigate the molecular mechanisms, potential targets, and therapeutic strategies associated with asthma severity. Notably, Reperixin displays the ability to target CXCR1, CXCR2, and MMP9, suggesting its potential therapeutic value for managing deteriorating asthma.
Countstar Connection
Within the study, Countstar (model not specified) measured cell numbers in the study's cell samples during sample-quality assessment.
View paper ↗
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online
Products
About Us
Contact
© 2026 Countstar. All rights reserved.